by Eric Christianson | Dec 11, 2024 | Renal, Urology, and Electrolytes Case Studies
I get a little nervous when I see high-dose potassium. Here’s a case scenario where a patient is on a higher dose. WL is a 77 year old male in an assisted living facility. He has a history of CHF, anxiety, pain, GERD, BPH, and constipation. His current...
by Eric Christianson | Dec 8, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Fosfomycin is an antibiotic (discovered in 1969) that has been making a resurgence in popularity in the last few years due to its activity against both gram-positive and gram-negative bacteria. Currently, it is a treatment option for women with uncomplicated urinary...
by Eric Christianson | Dec 4, 2024 | Clinical Pharmacy News and New Drug Updates
For decades, the clozapine REMS program was one of the most well-known safety initiatives done by the FDA. The program was designed to reduce the risk of severe neutropenia. This REMS program has also been a popular target for board exam questions. But is the...
by Eric Christianson | Nov 27, 2024 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Methenamine is a medication used for urinary tract infection (UTI) prophylaxis, however, it is not considered a traditional antibiotic. It works by acidifying the urine and essentially making it sterile by killing off existing bacteria in the urinary tract and...
by Eric Christianson | Nov 24, 2024 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls
Insulin icodec may have a new competitor in the near future. Insulin efsitora is another once-weekly insulin currently undergoing phase 3 clinical trials, with Lilly’s 3rd phase being termed the QWINT trials (Once Weekly (QW) Insulin Therapy (INT)). These trials are...
